Compare CMPR & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPR | CLDX |
|---|---|---|
| Founded | 1994 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2005 | 1995 |
| Metric | CMPR | CLDX |
|---|---|---|
| Price | $69.87 | $28.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $86.50 | $44.50 |
| AVG Volume (30 Days) | 84.8K | ★ 857.8K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.26 | N/A |
| Revenue | ★ $3,403,079,000.00 | $12,743,000.00 |
| Revenue This Year | $10.43 | $97.61 |
| Revenue Next Year | $5.46 | $252.01 |
| P/E Ratio | $30.92 | ★ N/A |
| Revenue Growth | 3.38 | ★ 87.78 |
| 52 Week Low | $35.28 | $14.40 |
| 52 Week High | $82.43 | $31.85 |
| Indicator | CMPR | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 51.12 |
| Support Level | $69.56 | $24.70 |
| Resistance Level | $75.75 | $30.90 |
| Average True Range (ATR) | 2.77 | 1.22 |
| MACD | 0.08 | -0.14 |
| Stochastic Oscillator | 37.57 | 1.88 |
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.